Oramed Pharmaceuticals, Inc. (OQ:ORMP)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for ORMP within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 14/20 Jan 8/20 Sank Leonard Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Jan 14/20 Jan 8/20 Rakin Kevin Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Jan 14/20 Jan 8/20 Mayer Arie Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Jan 14/20 Jan 8/20 Kidron Nadav Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 190,000  
Jan 14/20 Jan 8/20 Kidron Miriam Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 100,000  
Jan 14/20 Jan 8/20 Xiaoming Gao Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Jan 14/20 Jan 8/20 Friedman Aviad Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Dec 11/19 Dec 11/19 Mayer Arie Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sep 16/19 Sep 16/19 Hexter Joshua Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sep 16/19 Sep 12/19 Rakin Kevin Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ORMP within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 14/20 Jan 8/20 Sank Leonard Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Jan 14/20 Jan 8/20 Rakin Kevin Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Jan 14/20 Jan 8/20 Mayer Arie Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Jan 14/20 Jan 8/20 Kidron Nadav Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 190,000  
Jan 14/20 Jan 8/20 Kidron Miriam Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 100,000  
Jan 14/20 Jan 8/20 Xiaoming Gao Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Jan 14/20 Jan 8/20 Friedman Aviad Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Dec 11/19 Dec 11/19 Mayer Arie Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sep 16/19 Sep 12/19 Rakin Kevin Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,000  
Sep 16/19 Apr 10/19 Rakin Kevin Direct Ownership Stock Option (right to buy) D - Disposition to issuer under Rule 16b-3(e) -10,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ORMP

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Seattle Genetics (OQ:SGEN)
Alnylam Pharmaceuticals (OQ:ALNY)